Share price & Turnover
Description
| Country | Denmark |
|---|---|
| List | Spotlight DK |
| Sector | Health care |
| Industry | Drugs & Trade |
CS MEDICA ("CS MEDICA" or the "Company") announces today that the Company has signed an distributor agreement with NaturaMedica. The agreement covers the territory of Slovenia and includes 4 of CS MEDICA's medical device products under the CANNASEN brand. The order amounts to 20,700 units, corresponding to DKK 0,9 million in revenue which will be distributed over a 3.5-year period.
Lone Henriksen, CEO of CS MEDICA, pronounces:
"I am very glad to announce that CS MEDICA continues to expand on the European market. The Agreement with NaturaMedica demonstrates that our products are wanted and gives us a broader customer base in Europe. We hope that this agreement will spark more interest around Europe as we continue our expansion."
CS MEDICA reveals today that the Company has signed a distributor agreement with NaturaMedica. NaturaMedica (https://eur05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.naturamedica.si%2F&data=05%7C01%7C%7C06f4700858d845b39b6c08da582da188%7C1a85fb5101ea4c1581b68ca5cc0404f6%7C0%7C0%7C637919250267065005%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=OZ6MT3CsKh0oez6mTXmsL1HAeZmT0jq%2BNXGVb0vdgqQ%3D&reserved=0) is a company with a great network and extensive market know-how in Slovenia, covering both pharmacies and connections to associations as well as doctors. The focus will be on the Arthritis Gel and Pain Patch as the first launch followed by Psoriasis Gel and Nasal Spray Night later this year.
The order corresponds to DKK 0,9 million in revenue which will be distributed over a 3.5-year period. A breakdown of the annual order allocation is disclosed below.
2022: 3,200 units
2023: 3,500 units
2023: 3,600 units
2024: 10,400 units
CS MEDICA's products will be introduced to the Slovenian market later, after this summer.
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-06-2022 08:05 CET.